Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-138549
Filing Date
2021-04-29
Accepted
2021-04-29 09:00:59
Documents
5
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d41208ddef14a.htm DEF 14A 322316
2 GRAPHIC g41208g76l06.jpg GRAPHIC 60882
3 GRAPHIC g41208g80g80.jpg GRAPHIC 34110
4 GRAPHIC g41208page002.jpg GRAPHIC 159374
5 GRAPHIC g41208page003.jpg GRAPHIC 94260
  Complete submission text file 0001193125-21-138549.txt   791845
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38978 | Film No.: 21867395
SIC: 2834 Pharmaceutical Preparations